logo
Aleutian Capital Group Advises 1984 System, Inc. dba American Data in Its Sale to Valsoft Corporation

Aleutian Capital Group Advises 1984 System, Inc. dba American Data in Its Sale to Valsoft Corporation

Yahoo23-04-2025
NEW YORK, April 23, 2025--(BUSINESS WIRE)--Aleutian Capital Group ("Aleutian") is pleased to announce Valsoft Corporation ("Valsoft") successful acquisition of 1984 System, Inc. dba American Data ("American Data"). Aleutian acted as the exclusive advisor to American Data throughout the entire transaction process, providing comprehensive advisory services. Terms of the deal were not disclosed.
American Data has established itself as a trusted provider of electronic health record (EHR) software for the long-term care industry, offering customizable solutions that support both clinical and administrative needs. The company serves hundreds of facilities across the United States, including skilled nursing homes and assisted living communities. With a robust, all-in-one platform and decades of industry experience, American Data is committed to delivering exceptional reliability, user support, and innovation. Its software is widely recognized for flexibility, depth of features, and seamless integration across care teams.
Aleutian's managing director, Ji Sang Lee, led the engagement with American Data, facilitating the successful transaction. "The Aleutian team was instrumental throughout our transaction process. Their strategic guidance, responsiveness, and deep understanding of the software industry gave us the confidence to navigate every step. They weren't just advisors—they were true partners who helped us secure the right outcome for our team and our future," said John Ederer, Founder and President of American Data.
About American Data
American Data is trusted by hundreds of long-term care providers across the United States for its flagship solution, ECS (Electronic Chart System)—a fully customizable electronic health record (EHR) platform tailored to the unique workflows of senior care facilities. For over 40 years, administrators, nurses, and clinical teams have relied on ECS to integrate clinical, financial, and administrative functions, enabling seamless communication, real-time decision-making, and regulatory compliance. From independent communities to large multi-site operators, American Data is known for its exceptional support, deep industry expertise, and flexible software designed to evolve with the needs of the senior care industry. Visit www.american-data.com for more information.
About Valsoft Corporation
Valsoft acquires and develops vertical market software companies that deliver mission-critical solutions. A key tenet of Valsoft's philosophy is to invest in established businesses and foster an entrepreneurial environment that shapes a company into a leader in its respective industry. Unlike private equity and VC firms, Valsoft does not have a predefined investment horizon and looks to buy, hold, and create value through long-term partnerships with existing management and customers. Visit www.valsoftcorp.com for more information.
About Aleutian Capital Group
Aleutian is a New York City based advisory group serving sellers and buyers of companies throughout North and South America, Asia, and Europe. Aleutian has expertise in technology, distribution, e-commerce, healthcare, aerospace, consumer, transportation, professional services, and industrial manufacturing industries. Our investment banking practice, through our broker-dealer Bradley Woods & Co. Ltd. (Member FINRA/SIPC), provides services relating to M&A advisory, capital raises, valuations, and recapitalizations. All securities are offered through Bradley Woods & Co. Ltd., member FINRA and SIPC. Aleutian is a division of Bradley Woods & Co. Ltd., member FINRA and SIPC. For more information, please visit www.aleutiancapital.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250423765736/en/
Contacts
Ji Sang LeeManaging DirectorAleutian Captial Groupmarketing@aleutiancapital.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Develop Health Raises $14.3M to Automate Prior Authorization and Medication Access Using GenAI
Develop Health Raises $14.3M to Automate Prior Authorization and Medication Access Using GenAI

Business Wire

time8 hours ago

  • Business Wire

Develop Health Raises $14.3M to Automate Prior Authorization and Medication Access Using GenAI

SAN FRANCISCO--(BUSINESS WIRE)-- Develop Health, an EHR-integrated benefits‑verification and prior‑authorization platform, today announced a $14.3 million Series A led by Wing Venture Capital, with participation from Afore Capital, J Ventures, and South Park Commons. The round brings the company's total funding to $17.6 million. Built with over a dozen purpose-built large language model pipelines, Develop Health is the first medication access platform fully architected around GenAI. Its EHR-integrated platform plugs into virtual care workflows to verify insurance coverage in real time, generate and submit the correct prior authorization package, follow up and track status continuously, and return structured data back into the provider's system, all without manual effort from care teams. Founded by Mel van Londen and Benjamin Easton, Develop Health is tackling a growing bottleneck in healthcare: the administrative complexity that delays access to necessary medications. Before Develop Health, the founders held roles at provider-facing healthcare startups Canvas Medical and Rupa Health, where they saw how poor communication and data fidelity between providers and payers led to delayed treatment, lost revenue, and worse outcomes for patients. 'We believe providers should be able to make care decisions with full visibility into a patient's plan, because a prescription that isn't affordable or accessible is no prescription at all,' said Mel van Londen, co-founder and CEO of Develop Health. 'We're building healthcare's agentic clearinghouse, starting with medication access and designing infrastructure that meets both payers and providers where they are.' The new funding will fuel Develop Health's expansion beyond its core work helping digital health companies navigate the pharmacy benefit space—spanning GLP-1s and treatments across addiction, neurology, dermatology, and psychiatry—into the medical benefit market. The company will also deepen its integrations with both EHRs and PBMs, streamlining and scaling the link between prescribing and coverage, and extend its reach into traditional providers outside of digital health. 'Develop Health is solving one of the most frustrating pain points in healthcare – getting patients the medications they need without weeks of paperwork and endless back-and-forth,' said Sara Choi, Partner at Wing Venture Capital. 'They've built a system that puts GenAI to work in one of the industry's most critical, overlooked workflows. Develop Health is positioned to become essential infrastructure for any provider dealing with medication access complexity. ' Today, Develop Health helps providers reduce churn, set clearer patient expectations, and streamline access to care. The platform reduces form completion time by over 80% and increases approval rates, improving both provider efficiency and patient experience. In just three months, the company has grown significantly and is on track to helping over 1 million patients access their medications by the end of this year. That traction has been driven by Develop Health's exceptional team of engineers, including Jack Collins, Juan de Urtubey, and Zygimantas Koncius, whose technical excellence has made the platform possible. About Develop Health Develop Health's mission is to empower providers by eliminating the friction of prior authorization and improving visibility into plan benefits—freeing up capacity to deliver truly high-quality patient care. At its core, Develop Health is healthcare's agentic clearinghouse, beginning with medication access. Today, the platform supports hundreds of thousands of patients each month in getting the treatments they need—while reducing administrative work related to medication access by 83%. Learn more at

Ambience Healthcare Unveils Chart Chat: The First AI Copilot Built Into the EHR
Ambience Healthcare Unveils Chart Chat: The First AI Copilot Built Into the EHR

Associated Press

time2 days ago

  • Associated Press

Ambience Healthcare Unveils Chart Chat: The First AI Copilot Built Into the EHR

Powered by OpenAI's Reinforcement Fine-Tuning technology, this first-in-class AI copilot delivers real-time, patient-specific, evidence-based insights, directly within the EHR, underpinned by trusted medical content from BMJ Best Practice SAN FRANCISCO, CA / ACCESS Newswire / August 18, 2025 / Ambience Healthcare has unveiled Chart Chat, a first-of-its-kind AI copilot designed to integrate directly within Epic's electronic health record (EHR) system to give healthcare providers context-aware clinical insights. Chart Chat combines patient chart data with medical content from BMJ Best Practice and OpenAI's Reinforcement Fine Tuning (RFT) technology to create a novel intelligence layer over the EHR. 'This technology can fundamentally change how physicians interact with the medical record,' said Trevor Satterfield, MD, ACMIO, St. Luke's Health System. 'It lets me ask specific questions about the patient's history or treatment, questions that could take minutes of searching to answer, and get clear, accurate responses in seconds.' Designed to combat the growing problem of information overload, Chart Chat enables healthcare providers to ask natural language questions about a patient's history, lab results, prior treatments, and risk factors, and receive relevant, structured answers in seconds. While health systems have experimented with creating their own in-house AI assistants for the EHR, Ambience is the first to launch a production-quality solution. Unlocking a New Class of Context-Aware Clinical Assistance What sets Chart Chat apart is that Ambience combines real-time notes from the patient visit with data from the patient's full medical record. This gives Chart Chat a clear picture of both the current encounter and past history, enabling healthcare providers to get faster, more accurate answers without switching between tools or piecing things together manually. Key Features for Chart Chat include: 'Over the past several years, we've built and deployed clinical AI that's trusted by thousands of physicians to support real-time documentation, coding, and patient care,' said Nikhil Buduma, Co-Founder and Chief Scientist at Ambience Healthcare. 'Chart Chat builds on that foundation, bringing together cutting-edge language models, real-time EHR context, and trusted clinical content to create the most advanced bedside assistant in healthcare. The launch of Chart Chat marks a pivotal moment for conversational chart intelligence in the United States.' Chart Chat is rolling out to Ambience users over the next several months. More info can be found on the Ambience website. About Ambience Healthcare Ambience Healthcare is the leading AI platform for documentation, coding, and clinical workflow, built to reduce administrative burden and protect revenue integrity at the point of care. Trusted by top health systems across North America, Ambience's platform is live across outpatient, emergency, and inpatient settings, supporting more than 100 specialties with real-time, coding-aware documentation. The platform integrates directly with Epic, Oracle Cerner, athenahealth, and other major EHRs. Founded in 2020 by Mike Ng and Nikhil Buduma, Ambience is headquartered in San Francisco and backed by Oak HC/FT, Andreessen Horowitz (a16z), OpenAI Startup Fund, Kleiner Perkins, and other leading investors. Media Contact Ambience Healthcare Karina Stabile Aria Marketing for Ambience Healthcare [email protected] 516.317.5835 SOURCE: Ambience press release

Oracle Unveils AI EHR to Accelerate Cloud Growth and Healthcare Reach
Oracle Unveils AI EHR to Accelerate Cloud Growth and Healthcare Reach

Yahoo

time5 days ago

  • Yahoo

Oracle Unveils AI EHR to Accelerate Cloud Growth and Healthcare Reach

Oracle ORCL has launched its next-generation Electronic Health Record (EHR) system for ambulatory providers in the United States, marking its most significant healthcare product update since acquiring Cerner for $28 billion in 2022. The new Oracle Health EHR features voice-activated navigation and conversational AI capabilities, allowing clinicians to use voice commands to access patient information such as recent lab results and current medications. Built from the ground up on Oracle Cloud Infrastructure, the platform represents a departure from traditional EHR systems by eliminating multiple screens and clicks in favour of an intuitive, voice-first interface designed to reduce administrative burden on healthcare AI-powered EHR launch represents a critical inflection point that could significantly impact the company's healthcare revenue trajectory, particularly as it seeks to justify its $28 billion Cerner acquisition. The rollout supports Oracle's strong revenue momentum demonstrated in its fourth-quarter fiscal 2025 results, where total revenues reached $15.9 billion, up 11% year over year, indicating this healthcare innovation could further accelerate growth. The new EHR platform's voice-first approach aims to strengthen Oracle's competitive position in the healthcare market, building on cloud services and license support revenues of $11.7 billion in the fourth quarter of fiscal 2025, up 14% year over year. Oracle's infrastructure subscription revenues of $6.7 billion, up 19% year over year, indicate strong cloud adoption that the AI-driven EHR could amplify by attracting healthcare customers seeking next-generation solutions. Competitive Landscape and Strategic Positioning The AI-powered EHR announcement positions Oracle to compete against established market leaders in healthcare technology. Amazon AMZN has been expanding its healthcare technology presence through AWS cloud infrastructure and HealthLake data analytics platform, positioning Amazon as both a cloud infrastructure competitor and a potential healthcare technology partner. The company's healthcare initiatives represent a significant competitive threat to Oracle's cloud infrastructure ambitions, as Amazon continues investing heavily in healthcare technology MSFT has emerged as a preferred cloud infrastructure partner for Epic customers, with health systems increasingly choosing Microsoft Azure for EHR migrations due to existing business relationships. Microsoft's positioning in the healthcare cloud space represents both an opportunity and a challenge for Oracle's infrastructure ambitions, as Microsoft continues strengthening healthcare technology partnerships. Additionally, Veradigm Inc. MDRX holds a significant position in the ambulatory EHR market, focusing on specialized solutions for smaller practices. Veradigm has been adapting its strategy to compete against larger players by targeting niche outpatient markets, though Veradigm faces increasing pressure from Oracle's expanded healthcare offerings. Investment Outlook: Positive Oracle's AI-driven EHR represents a strategic pivot that could reshape its competitive position in healthcare technology. The voice-first, AI-integrated approach addresses longstanding physician complaints about traditional EHR systems being cumbersome and time-consuming. However, success will depend on Oracle's ability to rebuild customer confidence following integration challenges post-Cerner acquisition. The healthcare technology sector's high switching costs suggest Oracle's new EHR must demonstrate substantial advantages to drive meaningful adoption and support its fiscal 2026 revenue guidance of over $67 billion. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (AMZN) : Free Stock Analysis Report Microsoft Corporation (MSFT) : Free Stock Analysis Report Veradigm Inc. (MDRX) : Free Stock Analysis Report Oracle Corporation (ORCL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store